Patient Portal

Nuri Farber, MD

Professor, Psychiatry
Director, Psychiatry Residency Training Program
Director, Animal Neuropathology Core Facility     

Specialty Areas

Adult Psychiatry

Areas of Clinical Interest

Adult psychiatry, psychosis, ECT, mental retardation, schizophrenia, major depression, psychopharmacology 

  • Education
  • Publication & Research



Residency: Psychiatry, Washington University School of Medicine, St. Louis, Missouri 1993
Medical Degree: Washington University School of Medicine, St. Louis, Missouri 1989
Bachelor of Arts: Washington University, St. Louis, Missouri 1985

Publication & Research

Publication & Research

Noguchi KK, Cabrera OH, Swiney BS, Salinas-Contreras P, Smith JK, Farber NB (2015 Nov). Hedgehog regulates cerebellar progenitor cell and medulloblastoma apoptosis. Neurobiol Dis. 83:35-43.  

Hanslick JL, Lau K, Noguchi KK, Olney JW, Zorumski CF, Mennerick S, Farber NB (2009 Apr). Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system. Neurobiol Dis. 34(1): 1-10.  

Farber NB, Creeley CE, Olney JW (2010 Oct). Alcohol-induced neuroapoptosis in the fetal macaque brain. Neurobiol Dis. 40(1): 200-6.  

Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T, Craft S, Olney JW (1999 Feb). Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology. 20(2): 106-18.  

Lenze EJ, Farber NB, Kharasch E, Schweiger J, Yingling M, Olney J, Newcomer JW (2016 Apr). Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial. World J Biol Psychiatry. (3):230-8  

Farber NB (2003 Nov). The NMDA receptor hypofunction model of psychosis. Ann N Y Acad Sci. 1003119-30.  

Areas of Research Interest

The use of ketamine for treatment resistant depression; the ability of neuroactive chemicals/compounds, prescribed drugs, and abused drugs to injure/kill neurons and glia in the central nervous system